The American Gastroenterological Association’s new guideline on Barrett’s esophagus focuses on updates for endoscopic eradication therapy (EET). Key highlights include management of low-grade dysplasia, the use of endoscopic resection techniques, and the need for expert consultations. The guideline emphasizes the importance of shared decision-making between doctors and patients, weighing risks and benefits of EET.
GEN’s Sarah Tilyou spoke with Joel H. Rubenstein, MD, a research scientist at the Veterans Affairs Center for Clinical Management Research and professor of gastroenterology and the director of the Barrett’s Esophagus Program at the University of Michigan, in Ann Arbor, about the guideline and its implications for GI practice.https://www.gastroendonews.com/Esophageal-Disorders/Article/09-24/endoscopic-eradication-therapy-Barrett-s-esophagus-AGA-guideline-Joel-H-Rubenstein-MD/74803
Keep Reading
Add A Comment